Copyright Reports & Markets. All rights reserved.

Global Superoxide Dismutase [Cu-Zn] Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Superoxide Dismutase [Cu-Zn] Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Superoxide Dismutase [Cu-Zn] Market Size Growth Rate by Product
      • 1.4.2 AP-101
      • 1.4.3 WTX-101
      • 1.4.4 VYSOD-101
      • 1.4.5 TDI-186
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Superoxide Dismutase [Cu-Zn] Market Size Growth Rate by End User
      • 1.5.2 Amyotrophic Lateral Sclerosis
      • 1.5.3 Breast Cancer
      • 1.5.4 Parkinson's Disease
      • 1.5.5 Wilson Disease
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Superoxide Dismutase [Cu-Zn] Market Size
      • 2.1.1 Global Superoxide Dismutase [Cu-Zn] Revenue 2014-2025
      • 2.1.2 Global Superoxide Dismutase [Cu-Zn] Sales 2014-2025
    • 2.2 Superoxide Dismutase [Cu-Zn] Growth Rate by Regions
      • 2.2.1 Global Superoxide Dismutase [Cu-Zn] Sales by Regions
      • 2.2.2 Global Superoxide Dismutase [Cu-Zn] Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Superoxide Dismutase [Cu-Zn] Sales by Manufacturers
      • 3.1.1 Superoxide Dismutase [Cu-Zn] Sales by Manufacturers
      • 3.1.2 Superoxide Dismutase [Cu-Zn] Sales Market Share by Manufacturers
      • 3.1.3 Global Superoxide Dismutase [Cu-Zn] Market Concentration Ratio (CR5 and HHI)
    • 3.2 Superoxide Dismutase [Cu-Zn] Revenue by Manufacturers
      • 3.2.1 Superoxide Dismutase [Cu-Zn] Revenue by Manufacturers (2014-2019)
      • 3.2.2 Superoxide Dismutase [Cu-Zn] Revenue Share by Manufacturers (2014-2019)
    • 3.3 Superoxide Dismutase [Cu-Zn] Price by Manufacturers
    • 3.4 Superoxide Dismutase [Cu-Zn] Manufacturing Base Distribution, Product Types
      • 3.4.1 Superoxide Dismutase [Cu-Zn] Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Superoxide Dismutase [Cu-Zn] Product Type
      • 3.4.3 Date of International Manufacturers Enter into Superoxide Dismutase [Cu-Zn] Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Superoxide Dismutase [Cu-Zn] Sales by Product
    • 4.2 Global Superoxide Dismutase [Cu-Zn] Revenue by Product
    • 4.3 Superoxide Dismutase [Cu-Zn] Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Superoxide Dismutase [Cu-Zn] Breakdown Data by End User

    6 North America

    • 6.1 North America Superoxide Dismutase [Cu-Zn] by Countries
      • 6.1.1 North America Superoxide Dismutase [Cu-Zn] Sales by Countries
      • 6.1.2 North America Superoxide Dismutase [Cu-Zn] Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Superoxide Dismutase [Cu-Zn] by Product
    • 6.3 North America Superoxide Dismutase [Cu-Zn] by End User

    7 Europe

    • 7.1 Europe Superoxide Dismutase [Cu-Zn] by Countries
      • 7.1.1 Europe Superoxide Dismutase [Cu-Zn] Sales by Countries
      • 7.1.2 Europe Superoxide Dismutase [Cu-Zn] Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Superoxide Dismutase [Cu-Zn] by Product
    • 7.3 Europe Superoxide Dismutase [Cu-Zn] by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Superoxide Dismutase [Cu-Zn] by Countries
      • 8.1.1 Asia Pacific Superoxide Dismutase [Cu-Zn] Sales by Countries
      • 8.1.2 Asia Pacific Superoxide Dismutase [Cu-Zn] Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Superoxide Dismutase [Cu-Zn] by Product
    • 8.3 Asia Pacific Superoxide Dismutase [Cu-Zn] by End User

    9 Central & South America

    • 9.1 Central & South America Superoxide Dismutase [Cu-Zn] by Countries
      • 9.1.1 Central & South America Superoxide Dismutase [Cu-Zn] Sales by Countries
      • 9.1.2 Central & South America Superoxide Dismutase [Cu-Zn] Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Superoxide Dismutase [Cu-Zn] by Product
    • 9.3 Central & South America Superoxide Dismutase [Cu-Zn] by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Superoxide Dismutase [Cu-Zn] by Countries
      • 10.1.1 Middle East and Africa Superoxide Dismutase [Cu-Zn] Sales by Countries
      • 10.1.2 Middle East and Africa Superoxide Dismutase [Cu-Zn] Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Superoxide Dismutase [Cu-Zn] by Product
    • 10.3 Middle East and Africa Superoxide Dismutase [Cu-Zn] by End User

    11 Company Profiles

    • 11.1 AveXis Inc
      • 11.1.1 AveXis Inc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 AveXis Inc Superoxide Dismutase [Cu-Zn] Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 AveXis Inc Superoxide Dismutase [Cu-Zn] Products Offered
      • 11.1.5 AveXis Inc Recent Development
    • 11.2 Ionis Pharmaceuticals Inc
      • 11.2.1 Ionis Pharmaceuticals Inc Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Ionis Pharmaceuticals Inc Superoxide Dismutase [Cu-Zn] Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Ionis Pharmaceuticals Inc Superoxide Dismutase [Cu-Zn] Products Offered
      • 11.2.5 Ionis Pharmaceuticals Inc Recent Development
    • 11.3 ProMIS Neurosciences Inc
      • 11.3.1 ProMIS Neurosciences Inc Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 ProMIS Neurosciences Inc Superoxide Dismutase [Cu-Zn] Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 ProMIS Neurosciences Inc Superoxide Dismutase [Cu-Zn] Products Offered
      • 11.3.5 ProMIS Neurosciences Inc Recent Development
    • 11.4 Voyager Therapeutics Inc
      • 11.4.1 Voyager Therapeutics Inc Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Voyager Therapeutics Inc Superoxide Dismutase [Cu-Zn] Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Voyager Therapeutics Inc Superoxide Dismutase [Cu-Zn] Products Offered
      • 11.4.5 Voyager Therapeutics Inc Recent Development
    • 11.5 Wilson Therapeutics AB
      • 11.5.1 Wilson Therapeutics AB Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Wilson Therapeutics AB Superoxide Dismutase [Cu-Zn] Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Wilson Therapeutics AB Superoxide Dismutase [Cu-Zn] Products Offered
      • 11.5.5 Wilson Therapeutics AB Recent Development

    12 Future Forecast

    • 12.1 Superoxide Dismutase [Cu-Zn] Market Forecast by Regions
      • 12.1.1 Global Superoxide Dismutase [Cu-Zn] Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Superoxide Dismutase [Cu-Zn] Revenue Forecast by Regions 2019-2025
    • 12.2 Superoxide Dismutase [Cu-Zn] Market Forecast by Product
      • 12.2.1 Global Superoxide Dismutase [Cu-Zn] Sales Forecast by Product 2019-2025
      • 12.2.2 Global Superoxide Dismutase [Cu-Zn] Revenue Forecast by Product 2019-2025
    • 12.3 Superoxide Dismutase [Cu-Zn] Market Forecast by End User
    • 12.4 North America Superoxide Dismutase [Cu-Zn] Forecast
    • 12.5 Europe Superoxide Dismutase [Cu-Zn] Forecast
    • 12.6 Asia Pacific Superoxide Dismutase [Cu-Zn] Forecast
    • 12.7 Central & South America Superoxide Dismutase [Cu-Zn] Forecast
    • 12.8 Middle East and Africa Superoxide Dismutase [Cu-Zn] Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Superoxide Dismutase [Cu-Zn] Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Superoxide Dismutase [Cu-Zn] market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Superoxide Dismutase [Cu-Zn] market based on company, product type, end user and key regions.

      This report studies the global market size of Superoxide Dismutase [Cu-Zn] in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Superoxide Dismutase [Cu-Zn] in these regions.
      This research report categorizes the global Superoxide Dismutase [Cu-Zn] market by top players/brands, region, type and end user. This report also studies the global Superoxide Dismutase [Cu-Zn] market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      AveXis Inc
      Ionis Pharmaceuticals Inc
      ProMIS Neurosciences Inc
      Voyager Therapeutics Inc
      Wilson Therapeutics AB

      Market size by Product
      AP-101
      WTX-101
      VYSOD-101
      TDI-186
      Others
      Market size by End User
      Amyotrophic Lateral Sclerosis
      Breast Cancer
      Parkinson's Disease
      Wilson Disease
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Superoxide Dismutase [Cu-Zn] market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Superoxide Dismutase [Cu-Zn] market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Superoxide Dismutase [Cu-Zn] companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Superoxide Dismutase [Cu-Zn] submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Superoxide Dismutase [Cu-Zn] are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Superoxide Dismutase [Cu-Zn] market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now